BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 29393341)

  • 1. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression.
    Nagai H; Hasegawa S; Uchida F; Terabe T; Ishibashi Kanno N; Kato K; Yamagata K; Sakai S; Kawashiri S; Sato H; Yanagawa T; Bukawa H
    Int J Oncol; 2018 Mar; 52(3):841-850. PubMed ID: 29393341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
    Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
    Wang K; Jin J; Ma T; Zhai H
    J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3.
    Feng X; Luo Q; Wang H; Zhang H; Chen F
    J Cell Physiol; 2018 Sep; 233(9):6705-6713. PubMed ID: 29319163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
    Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
    Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
    Fukumoto I; Hanazawa T; Kinoshita T; Kikkawa N; Koshizuka K; Goto Y; Nishikawa R; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2015 Mar; 112(5):891-900. PubMed ID: 25668004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
    Du Y; Li Y; Lv H; Zhou S; Sun Z; Wang M
    Int J Clin Exp Pathol; 2015; 8(10):12252-9. PubMed ID: 26722410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
    Wang K; Jin J; Ma T; Zhai H
    Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
    Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of matrix metalloproteinase 14 by the antitumor miRNA, miR-150-5p, inhibits the aggressiveness of lung squamous cell carcinoma cells.
    Suetsugu T; Koshizuka K; Seki N; Mizuno K; Okato A; Arai T; Misono S; Uchida A; Kumamoto T; Inoue H
    Int J Oncol; 2018 Mar; 52(3):913-924. PubMed ID: 29286099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
    Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
    Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
    Ji L; Zhu ZN; He CJ; Shen X
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
    Wang X; Li F; Zhou X
    Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.
    Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L
    Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.